NCT00057213 - An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder | Biotech Hunter

Enrollment

367

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

Depressive Disorder, Major

Interventions

DRUG

Radafaxine

Trial Locations (21)

2301

GSK Investigational Site, Brockton

10021

GSK Investigational Site, New York

19106

GSK Investigational Site, Philadelphia

27514

GSK Investigational Site, Chapel Hill

27609

GSK Investigational Site, Raleigh

32789

GSK Investigational Site, Winter Park

33173

GSK Investigational Site, Miami

41042

GSK Investigational Site, Florence

44124

GSK Investigational Site, Lyndhurst

47802

GSK Investigational Site, Terre Haute

62702

GSK Investigational Site, Springfield

77555

GSK Investigational Site, Galveston

77566

GSK Investigational Site, Lake Jackson

78756

GSK Investigational Site, Austin

84107

GSK Investigational Site, Salt Lake City

85251

GSK Investigational Site, Scottsdale

91950

GSK Investigational Site, National City

92618

GSK Investigational Site, Irvine

92845

GSK Investigational Site, Garden Grove

97401

GSK Investigational Site, Eugene

85381 - 4828

GSK Investigational Site, Peoria